1. Home
  2. DOMO vs VYGR Comparison

DOMO vs VYGR Comparison

Compare DOMO & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMO
  • VYGR
  • Stock Information
  • Founded
  • DOMO 2010
  • VYGR 2013
  • Country
  • DOMO United States
  • VYGR United States
  • Employees
  • DOMO N/A
  • VYGR N/A
  • Industry
  • DOMO Computer Software: Prepackaged Software
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • DOMO Technology
  • VYGR Health Care
  • Exchange
  • DOMO Nasdaq
  • VYGR Nasdaq
  • Market Cap
  • DOMO 286.1M
  • VYGR 309.7M
  • IPO Year
  • DOMO 2018
  • VYGR 2015
  • Fundamental
  • Price
  • DOMO $7.98
  • VYGR $6.45
  • Analyst Decision
  • DOMO Hold
  • VYGR Strong Buy
  • Analyst Count
  • DOMO 5
  • VYGR 9
  • Target Price
  • DOMO $10.10
  • VYGR $16.44
  • AVG Volume (30 Days)
  • DOMO 283.4K
  • VYGR 570.6K
  • Earning Date
  • DOMO 12-05-2024
  • VYGR 11-12-2024
  • Dividend Yield
  • DOMO N/A
  • VYGR N/A
  • EPS Growth
  • DOMO N/A
  • VYGR N/A
  • EPS
  • DOMO N/A
  • VYGR 0.47
  • Revenue
  • DOMO $318,369,000.00
  • VYGR $163,784,000.00
  • Revenue This Year
  • DOMO $0.39
  • VYGR N/A
  • Revenue Next Year
  • DOMO N/A
  • VYGR N/A
  • P/E Ratio
  • DOMO N/A
  • VYGR $13.83
  • Revenue Growth
  • DOMO 0.19
  • VYGR 3.40
  • 52 Week Low
  • DOMO $6.11
  • VYGR $5.19
  • 52 Week High
  • DOMO $12.23
  • VYGR $11.72
  • Technical
  • Relative Strength Index (RSI)
  • DOMO 38.01
  • VYGR 51.85
  • Support Level
  • DOMO $9.14
  • VYGR $6.13
  • Resistance Level
  • DOMO $10.15
  • VYGR $7.44
  • Average True Range (ATR)
  • DOMO 0.44
  • VYGR 0.34
  • MACD
  • DOMO -0.08
  • VYGR 0.09
  • Stochastic Oscillator
  • DOMO 11.42
  • VYGR 56.00

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: